| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |